ABEO
Abeona Therapeutics Inc
5.00$
-2.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -4.0% | +0.4% | -5.4% | +5.4% | +7.5% | +5.0% | -5.8% | +15.6% | +23.0% | -20.4% | -4.1% | – | |
| – | -2.8% | +2.1% | -14.4% | +36.4% | +8.4% | +38.2% | +4.8% | -5.0% | -105.3% | – | +13.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -57.0% | -377.5% | – | -107.3% | – | – | – | -208.8% | – | – | – | – | |
| – | -15.9% | +1,859.5% | -1.9% | -43.2% | +50.0% | +131.2% | +107.1% | -13.1% | -54.2% | -18.9% | -48.8% | – | |
| – | – | -167.8% | +464.6% | -86.0% | – | -77.7% | +3,600.2% | -141.5% | – | -48.1% | +216.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +50.0% | – | |
| – | -67.5% | +240.7% | +189.6% | -100.4% | – | +27.4% | +55.1% | -50.8% | -30.0% | -161.5% | +50.1% | – | |
| – | – | -68.4% | +446.8% | -210.9% | – | -197.2% | – | -154.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.